文献速递临床试验与 GCP

双侧竖脊肌平面阻滞在上腹部手术中的阿片类药物节省效应:双中心前瞻性随机对照试验研究方案

Bilateral erector spinae plane block on opioid-sparing effect in upper abdominal surgery: study protocol for a bi-center prospective randomized controlled trial.
PubMed 文献 · Trials · 2024-11-13

本研究为双中心前瞻性随机对照非劣效试验,计划纳入158例上腹部手术患者,随机接受术前双侧竖脊肌平面阻滞(ESPB)或胸椎旁阻滞(PVB)。主要结局为术中舒芬太尼等效累积镇痛剂量,次要结局包括术后并发症及术后24小时、48小时和30天的恢复质量-15评分。

要点

  • 拟纳入158例上腹部手术患者,随机接受双侧ESPB或PVB。
  • 主要结局为术中舒芬太尼等效累积镇痛剂量。
  • 次要结局包括术后并发症及恢复质量-15评分。

核心结论

  • 本研究将评估ESPB与PVB的阿片类药物节省效应、并发症及恢复质量。

研究设计与样本

  • 双中心前瞻性随机对照非劣效试验,计划纳入158例上腹部手术患者。
  • 患者随机接受术前双侧竖脊肌平面阻滞(ESPB)或胸椎旁阻滞(PVB)。

关键数值与推荐

  • 主要结局为术中舒芬太尼等效累积镇痛剂量,定义为从麻醉诱导至气管拔管期间舒芬太尼的总剂量。
  • 主要次要结局包括术后并发症及术后24小时、48小时和30天的恢复质量-15评分。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Erector spinae plane block (ESPB) is a promising technique for effective analgesia. It is still uncertain if ESPB offers the same opioid-sparing effect as thoracic paravertebral block (PVB) in midline incision for upper abdominal surgery. METHODS: The study is a prospective, bi-center, randomized, controlled, non-inferior trial. One hundred fifty-eight patients scheduled for upper abdominal surgery will be randomly assigned to receive bilateral ESPB or PVB before surgery. The primary outcome will be the equivalent cumulative analgesia dosage of sufentanil during the surgery, which is defined as the total dosage of sufentanil from anesthesia induction to tracheal extubation. The main secondary outcomes include postoperative complications and the quality of recovery-15 score at 24 h, 48 h, and 30 days after surgery. DISCUSSION: This study will assess the opioid-sparing efficacy of ESPB and PVB, complications, and the quality of recovery of two blocks. TRIAL REGISTRATION: ChiCTR2300073030 ( https://www.chictr.org.cn/ ). Registered on 30 June 2023.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Geng C, Wang L, Shi Y, et al. Bilateral erector spinae plane block on opioid-sparing effect in upper abdominal surgery: study protocol for a bi-center prospective randomized controlled trial. Trials. 2024. PMID: 39538323. doi:10.1186/s13063-024-08612-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。